Fusion Antibodies plc (FAB.L)

GBp 6.55

(0.77%)

EBITDA Summary of Fusion Antibodies plc

Fusion Antibodies plc's latest annual EBITDA in 2023 was -2.06 Million GBP , up 15.81% from previous year.
Fusion Antibodies plc's latest quarterly EBITDA in 2023 FY was N/A , up 15.81% from previous quarter.
Fusion Antibodies plc reported an annual EBITDA of -2.48 Million GBP in 2022, down -323.58% from previous year.
Fusion Antibodies plc reported an annual EBITDA of -573 Thousand GBP in 2021, up 12.63% from previous year.
Fusion Antibodies plc reported a quarterly EBITDA of -1.29 Million GBP for 2023 Q2, down 0.0% from previous quarter.
Fusion Antibodies plc reported a quarterly EBITDA of -778 Thousand GBP for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Fusion Antibodies plc (2023 - 2012)

Historical Annual EBITDA of Fusion Antibodies plc (2023 - 2012)

Year	EBITDA	EBITDA Growth
2023	-2.06 Million GBP	15.81%
2022	-2.48 Million GBP	-323.58%
2021	-573 Thousand GBP	12.63%
2020	-532 Thousand GBP	-35.16%
2019	-431 Thousand GBP	53.79%
2018	-1.06 Million GBP	-906.42%
2017	-636.87 Thousand GBP	-17.24%
2016	288.47 Thousand GBP	219.54%
2015	49.92 Thousand GBP	162.91%
2014	-79.35 Thousand GBP	21.51%
2013	-101.09 Thousand GBP	77.27%
2012	-444.74 Thousand GBP	0.0%

Year	EBITDA	EBITDA Growth
2023 FY	- GBP	15.81%
2023 Q2	-1.29 Million GBP	0.0%
2023 Q4	-778 Thousand GBP	0.0%
2022 Q4	-1.48 Million GBP	0.0%
2022 FY	- GBP	-323.58%
2022 Q2	-1.01 Million GBP	0.0%
2021 FY	- GBP	12.63%
2021 Q4	-283 Thousand GBP	0.0%
2021 Q2	-321 Thousand GBP	0.0%
2020 Q2	-261 Thousand GBP	0.0%
2020 Q4	-468 Thousand GBP	0.0%
2020 FY	- GBP	-35.16%
2019 Q4	-125 Thousand GBP	0.0%
2019 Q2	-368 Thousand GBP	0.0%
2019 FY	- GBP	53.79%
2018 FY	- GBP	-906.42%
2018 Q4	-366 Thousand GBP	-37.51%
2018 Q3	-266.15 Thousand GBP	62.67%
2018 Q2	-713 Thousand GBP	-347.81%
2018 Q1	-159.21 Thousand GBP	-2105.78%
2017 Q2	124.08 Thousand GBP	211.13%
2017 Q4	7938.00 GBP	0.0%
2017 FY	- GBP	-17.24%
2017 Q1	39.88 Thousand GBP	0.0%
2016 Q1	12.48 Thousand GBP	0.0%
2016 FY	- GBP	219.54%
2016 Q4	39.88 Thousand GBP	0.0%
2016 Q3	39.88 Thousand GBP	0.0%
2015 Q4	12.48 Thousand GBP	0.0%
2015 Q3	12.48 Thousand GBP	162.91%
2015 FY	- GBP	162.91%
2015 Q2	-19.83 Thousand GBP	0.0%
2015 Q1	-19.83 Thousand GBP	0.0%
2014 Q4	-19.83 Thousand GBP	0.0%
2014 Q3	-19.83 Thousand GBP	0.0%
2014 FY	- GBP	21.51%
2013 FY	- GBP	77.27%
2012 FY	- GBP	0.0%

Peer EBITDA Comparison of Fusion Antibodies plc

Name	EBITDA	EBITDA Difference